Coordinated by EBC, EBRA enhances coordination and collaboration among members that share the common goal of understanding the brain and its disorders by synergising brain related projects and initiatives at both European and global level ...
Alzheimer’s Disease (AD) Detect & Prevent (ADDP)
admin_ebc2021-11-25T12:33:18+00:00The EU-funded AD Detect-Prevent project, which is led by the Danish company Brain+, kicked-off in late 2018 and will continue over the next two years with the aim of developing a digital tool to improve early detection of Alzheimer’s disease.
ASCTN-Training
admin_ebc2021-06-24T10:07:17+00:00ASCTN-Training is a four-year project, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 813851.
AETIONOMY
admin_ebc2020-03-18T20:39:24+00:00AETIONOMY is a consortium brought together under the European IMI to tackle the problem of the classification of neuro-degenerative diseases. Revising the taxonomy (classification) will take many years to complete and to be accepted by the biomedical community.
ADVANCE HTA
admin_ebc2023-07-19T10:18:24+00:00ADVANCE-HTA is a research project funded by the European Commission's Research Framework Programme (FP7). It comprises several complementary streams of research that aim to advance and strengthen the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA).
MARATONE
admin_ebc2020-03-18T20:38:57+00:00MARATONE is a Marie Curie Initial Training Network project that directly addresses the need for high-level training and career pathways in mental health to increase the inter-sectorial and trans-national employability of young scientists in the academic, public and private sectors to meet the enormous challenge of the 2009 EU Parliament Resolution on Mental Health.
NERRI
admin_ebc2020-03-18T20:38:44+00:00Science and technology advances rapidly. The NERRI project works to establish productive dialogue between potential users, potential “designers” (researchers, engineers, developers) and potential legislators of Neuro-Enhancement technologies, before products start to hit the marketplace.